Resultados del sistema Paradigm Real Time 722® en una serie de pacientes con diabetes mellitus tipo I

The Diabetes Control and Complications Trial Research Group, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 American Diabetes Association, 2008, Standards of medical care in diabetes-2008, Diabetes Care, 31, S12, 10.2337/dc08-S012 Bode, 2005, Glycemic characteristics in continuously monitored patients with Type 1 and Type 2 diabetes: normative values, Diabetes Care, 8, 2361, 10.2337/diacare.28.10.2361 Cryer, 2008, The barrier of hypoglycemia in diabetes, Diabetes, 57, 3169, 10.2337/db08-1084 Wentholt, 2007, Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations, Diabet Med, 24, 527, 10.1111/j.1464-5491.2007.02107.x Pickup, 2002, Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes, Diabetes Care, 25, 593, 10.2337/diacare.25.3.593 Wentholt, 2007, Continuous glucose monitors: the long-awaited watch dogs?, Diabetes Technol Ther, 9, 399, 10.1089/dia.2007.0215 Martín Vaquero, 2006, Implantación de los sistemas de infusión subcutánea de insulina (ISCI) en la Comunidad de Madrid, Av Diabetol, 22, 97 Vázquez, 2007, Situación actual del tratamiento con sistemas de infusión subcutánea de insulina (ISCI) en España, Av Diabetol, 23, 288 Pickup, 2008, Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion, Diabet Med, 25, 765, 10.1111/j.1464-5491.2008.02486.x Jeitler, 2008, Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus:systematicreviewandmeta-analysis, Diabetologia, 51, 941, 10.1007/s00125-008-0974-3 Fatourechi, 2009, Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections, J Clin Endocrinol Metab, 94, 729, 10.1210/jc.2008-1415 Misso, 2010, Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus, Cochrane Database Syst Rev, 20 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, 2008, Continuous glucose monitoring and intensive treatment of type 1 diabetes, N Engl J Med, 359, 1464, 10.1056/NEJMoa0805017 Hermanides, 2011, Sensor-augmented pump therapy lowers HbA1C in suboptimally controlled Type1 diabetes; a randomized controlled trial, Diabet Med, 10.1111/j.1464-5491.2011.03256.x Hirsch, 2008, Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study, Diabetes Technol Ther, 10, 377, 10.1089/dia.2008.0068 Halvorson, 2007, A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continous glucose monitoring with the insulin pump, J Pediatr, 150, 103, 10.1016/j.jpeds.2006.08.069 Bergenstal, 2010, Effectiveness of sensoraugmented insulin-pump therapy in type 1 diabetes, N Engl J Med, 363, 311, 10.1056/NEJMoa1002853 Kordonouri, 2010, Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment, Diabetologia, 53, 2487, 10.1007/s00125-010-1878-6 Raccah, 2009, Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study, Diabetes Care, 32, 2245, 10.2337/dc09-0750 Weinzimer, 2008, Sensor-augmented pump therapy in type 1 diabetes, Curr Opin Endocrinol Diabetes Obes, 15, 118, 10.1097/MED.0b013e3282f7960b Peyrot, 2009, Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system, Diabetes Technol Ther, 11, 57, 10.1089/dia.2008.0002 Anarte, 2010, Estudio longitudinal del impacto del tratamiento con infusores de insulina en variables psicológicas, la calidad de vida y el control glucémico de pacientes con diabetes mellitus tipo 1, Av Diabetol, 26, 112, 10.1016/S1134-3230(10)62008-X